Merck said on Wednesday a combination of its experimental drug and blockbuster therapy Keytruda failed a late-stage trial ...

Individuals who engage in heavy drinking over time should be particularly aware of this risk. 3. Colorectal Cancer Research ...

Research from the University of California, Irvine has revealed how disruption of the circadian clock, the body's internal, ...

Research from the University of California, Irvine has revealed how disruption of the circadian clock, the body's internal, ...

This TUNDRA comic was among the humorous images participants viewed in a study that yielded unique findings on the role of ...

【导读】结直肠癌(CRC)中错误折叠蛋白的长期积累导致内质网(ER)应激。然而，控制结直肠癌存活和凋亡的确切通路尚不清楚。 9月13日，南京医科大学傅赞研究团队在期刊《Journal of Experimental & Clinical Cancer ...

Factors related to sex and gender can affect therapy outcomes and should not be overlooked in clinical practice or research.

An attempt by Merck & Co. to unlock the microsatellite stable (MSS) metastatic colorectal cancer market has ended in failure.

Researchers also noticed that the mice used as models for Alzheimer’s disease who were given stool transplants from healthy ...

Merck & Co Inc (NYSE:MRK) released topline data from the KEYFORM-007 Phase 3 study of the fixed-dose combination of ...

Merck follows in the footsteps of Bristol Myers Squibb, which in December 2023 also failed to secure a late-stage victory for ...

"Stool-based test offers a promising solution to reduce the burden of a colonoscopy," experts emphasized on September 21st, ...